IOBTQ · IO Biotech, Inc.
$0.00
At close · Jul 27
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that the aforementioned conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are issued and therefore, the Company may not be able to continue its currently ongoing research and development activities as planned and realize its assets and satisfy its liabilities in the normal course of business.”View the 10-Q filed Nov 14, 2025
Market Cap
$71,948
Shares
71.95M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$95.5M
-10.9%
FY2024
Diluted EPS
-$1.45
+26.8%
FY2024
Operating Cash Flow
-$82.35M
-14.8%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| $67.92M | $71.48M | $67.83M | $46.99M | $30.15M | $8.46M | |
| $24.14M | $23.69M | $23.61M | $24.44M | $11.08M | $1.68M | |
| $300K | $300K | $200K | $100K | $0 | — | |
| $92.05M | $95.18M | $91.44M | $71.42M | $41.23M | $10.15M | |
| -$92.05M | -$95.18M | -$91.44M | -$71.42M | -$41.23M | -$10.15M | |
| — | — | — | $302K | $361K | $26K | |
| $2.75M | $1.13M | $6.21M | $1.24M | -$26.58M | -$1.9M | |
| -$89.3M | -$94.05M | -$85.23M | -$70.19M | -$67.81M | -$12.04M | |
| -$955K | $1.44M | $852K | $1.27M | $68K | — | |
| -$88.36M | -$95.5M | -$86.08M | -$71.46M | -$67.88M | -$12.04M | |
| -$88.35M | -$95.49M | -$86.08M | -$71.46M | -$74.99M | -$14.59M | |
| -$84.51M | -$92.67M | -$85.61M | -$80.11M | -$71.33M | -$11.38M | |
| USD/shares | — | -$1.45 | -$1.98 | -$2.48 | -$17.30 | — |
| USD/shares | — | -$1.45 | -$1.98 | -$2.48 | -$17.30 | — |
| shares | — | 65.88M | 43.54M | 28.82M | 4.34M | 177.2K |
| shares | — | 65.88M | 43.54M | 28.82M | 4.34M | 177.2K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.